secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2023-02-02T23:59:59+00:00
Accession:  0000898432-23-000037
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRadimed Q4 revenue $14.9M (+25% YoY); declares special $1.05 dividend; FY23 guidance $61-63M
--------------------------------------------------------------------------------

- Q4 2022 revenue $14.9M (vs $11.9M Q4 2021); GAAP diluted EPS $0.29; non-GAAP diluted EPS $0.32.
- Full-year 2022 revenue $53.3M (vs $41.8M FY2021); GAAP EPS $1.02; non-GAAP EPS $1.10.
- Board declared special cash dividend of $1.05/share, payable Feb 21, 2023 to holders of record Feb 13, 2023.
- FY 2023 guidance: revenue $61-63M, GAAP EPS $1.10-1.20, non-GAAP EPS $1.23-1.34; Q1 2023 revenue $14.6-14.9M.
- Cash and equivalents $57.9M, no debt; gross margin 77.4% for full year 2022 (up from 76.6%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000089843223000037/0000898432-23-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000089843223000037/form8k.htm
  HTML page:      https://secwatch.observer/filing/0000898432-23-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer